Assessment of Intranasal Corticosteroid Use in Allergic Rhinitis: Benefits, Costs, and Patient PreferencesByLeon Dupclay, Jr., PharmD,Joseph Doyle, RPh, MBASeptember 1st 2002
Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care PopulationByDaniel A. Ollendorf, MPH,Anna N. Peterson, BA,Joseph Doyle, RPh, MBA,Daniel M. Huse, MAMay 1st 2002
Comparison of Rheumatoid Arthritis Care Costs in Patients Starting Therapy with Leflunomide Versus EtanerceptByCyrus Yazdani, MS,Trent McLaughlin, PhD,Gordon Cummins, MS,Joseph Doyle, RPh, MBASeptember 1st 2001
